Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Beta 4 in Pressure Ulcers
NCT00382174Phase 2Completed
- Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Start
- May 2006
- Primary completion
- Dec 2008
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin beta-4 in pressure ulcer, sponsored by RegeneRx Biopharmaceuticals, Inc.. Started May 2006; status: completed.
02
Drugs
thymosin beta-4
03
Conditions
pressure ulcer
Beyond the preview
Go deeper on NCT00382174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00382174.